# NSCLC Agentic AI Platform

## í”„ë¡œì íŠ¸ ê°œìš”

**íì•”(NSCLC)** ì‹ ì•½ ê°œë°œì„ ìœ„í•œ **Agentic AI ì‹œìŠ¤í…œ**ì˜ í†µí•© í”Œë«í¼ì…ë‹ˆë‹¤. Palantir ìŠ¤íƒ€ì¼ì˜ ì‚¬ì´ë“œë°” ë„¤ë¹„ê²Œì´ì…˜ì„ í†µí•´ ì „ì²´ ì›Œí¬í”Œë¡œìš°ë¥¼ ê´€ë¦¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.

## ğŸ¯ í•µì‹¬ ëª©í‘œ

- âœ… **Evidence-Based Medicine**: ì¦ê±° ê¸°ë°˜ ì˜ì•½ ê°œë°œ ì§€ì›
- âœ… **Ontology-Driven**: RDF/OWL ì˜¨í†¨ë¡œì§€ ê¸°ë°˜ ì§€ì‹ ê´€ë¦¬
- âœ… **AI-Powered Reasoning**: SWRL ê¸°ë°˜ ì¶”ë¡  ì—”ì§„
- âœ… **Quality Assurance**: SHACL ê²€ì¦ì„ í†µí•œ ë°ì´í„° í’ˆì§ˆ ë³´ì¦
- âœ… **Clinical Decision Support**: í™˜ìë³„ ë§ì¶¤ ì¹˜ë£Œ ì¶”ì²œ

## ğŸŒ ì ‘ì† ì •ë³´

### **ê³µê°œ URL (GitHub Pages)**
```
https://myungdae.github.io/medicine/
```

### **GitHub ì €ì¥ì†Œ**
```
https://github.com/myungdae/medicine
```

## ğŸ“Š ì‹œìŠ¤í…œ êµ¬ì„±

### Core Modules

#### 1. ğŸ“Š Dashboard
- ì‹œìŠ¤í…œ ì „ì²´ í˜„í™© ëŒ€ì‹œë³´ë“œ
- ì‹¤ì‹œê°„ í†µê³„ (Evidence Items, Patient Cases, Active Drugs)
- ìµœê·¼ í™œë™ íƒ€ì„ë¼ì¸
- ì‹œìŠ¤í…œ ìƒíƒœ ëª¨ë‹ˆí„°ë§

#### 2. ğŸ’§ Hydrate Ontology
**ì¦ê±° ìˆ˜ì§‘ ë° êµ¬ì¡°í™” ëª¨ë“ˆ** (ê¸°ì¡´ ì…ë ¥ì°½)

**ëª©ì **: íŒë‹¨(ì¶”ì²œ)ì´ ì•„ë‹Œ, ì¦ê±°(Article)ì™€ ê´€ì¸¡ê°’(Observation/Result)ì˜ ë§¥ë½ ë³´ì¡´

**ê¸°ëŠ¥**:
- 5ê°œ íƒ­ ì¸í„°í˜ì´ìŠ¤
  - ğŸ“‹ ë©”íƒ€ë°ì´í„° (Evidence Type, Publication Date, DOI ë“±)
  - ğŸ“ ì›ë¬¸/ìš”ì•½ ì…ë ¥ (Abstract, Trial Summary)
  - ğŸ§¬ ì—”í‹°í‹°/ì½”í˜¸íŠ¸ (Gene, Alteration, Drug)
  - ğŸ“Š ê²°ê³¼ ìˆ˜ì¹˜ (ORR, PFS, OS, IC50)
  - ğŸ”’ ì‹ ë¢°ë„/ê±°ë²„ë„ŒìŠ¤ (Peer Review, Confidence Level)
- êµ¬ì¡°í™”ëœ JSON ìƒì„±
- ë°ì´í„° íŒŒì´í”„ë¼ì¸ ì—°ë™ ì¤€ë¹„

**ì§€ì› ë°ì´í„°**:
- Evidence Types: Paper, TrialSummary, Review, Preprint
- Cancer Focus: NSCLC
- Genes: EGFR, ALK
- Alterations: EGFR exon19 del, EGFR L858R, ALK fusion

#### 3. ğŸ“‹ Patient Cases
**ì„ìƒ ì‚¬ë¡€ ê´€ë¦¬ ëª¨ë“ˆ**

í™˜ìë³„ í”„ë¡œí•„, ì¹˜ë£Œ ì¶”ì²œ, ê·¼ê±° ì¶”ì ì„ ê´€ë¦¬í•©ë‹ˆë‹¤.

**ì˜ˆì‹œ ì¼€ì´ìŠ¤**:
- Case #037: NSCLC, EGFR exon19 del, 1L â†’ Drug_A ì¶”ì²œ
- Case #036: NSCLC, ALK fusion, 2L â†’ Alectinib ì¶”ì²œ

#### 4. ğŸ§  Reasoning Engine
**AI ê¸°ë°˜ ì¶”ë¡  ì—”ì§„** (ê°œë°œ ì˜ˆì •)

SWRL (Semantic Web Rule Language) ê¸°ë°˜ìœ¼ë¡œ:
- ì˜¨í†¨ë¡œì§€ ë°ì´í„° + í™˜ì í”„ë¡œí•„ â†’ ì¹˜ë£Œ ì¶”ì²œ
- ê·œì¹™ í¸ì§‘, ì¶”ë¡  ë¡œê·¸, ì‹ ë¢°ë„ ìŠ¤ì½”ì–´ë§

### Knowledge Base

#### 5. ğŸ“š Evidence Library
**ì¦ê±° ì•„ì´í…œ ì €ì¥ì†Œ** (ê°œë°œ ì˜ˆì •)

Hydrate Ontologyë¥¼ í†µí•´ ìˆ˜ì§‘ëœ ëª¨ë“  ì¦ê±°ë¥¼ ê²€ìƒ‰/ê´€ë¦¬:
- ê³ ê¸‰ ê²€ìƒ‰ ë° í•„í„°ë§
- RAG (Retrieval-Augmented Generation) í†µí•©
- ì¦ê±° í’ˆì§ˆ ë©”íŠ¸ë¦­

#### 6. ğŸ”¬ Ontology Browser
**ì˜¨í†¨ë¡œì§€ íƒìƒ‰ê¸°** (ê°œë°œ ì˜ˆì •)

RDF/OWL ê¸°ë°˜ ì˜¨í†¨ë¡œì§€ ì‹œê°í™”:
- ê·¸ë˜í”„ ê¸°ë°˜ ê´€ê³„ ì‹œê°í™”
- SPARQL ì¿¼ë¦¬ ì¸í„°í˜ì´ìŠ¤
- ì—”í‹°í‹° ê°„ ê´€ê³„ íƒìƒ‰

#### 7. âœ“ SHACL Validation
**ë°ì´í„° í’ˆì§ˆ ê²€ì¦** (ê°œë°œ ì˜ˆì •)

SHACL (Shapes Constraint Language) ê¸°ë°˜:
- í•„ìˆ˜ í•„ë“œ ê²€ì¦
- ë°ì´í„° íƒ€ì… ì²´í¬
- ê´€ê³„ ë¬´ê²°ì„± ê²€ì¦
- ìë™ ìˆ˜ì • ì œì•ˆ

### Analysis

#### 8. ğŸ’Š Drug Recommendations
**ì¹˜ë£Œ ì¶”ì²œ ì‹œìŠ¤í…œ** (ê°œë°œ ì˜ˆì •)

í™˜ìë³„ ë§ì¶¤ ì¹˜ë£Œ ì˜µì…˜:
- ë¹„êµ ë¶„ì„ (Comparative Analysis)
- ìœ„í—˜-ì´ìµ í‰ê°€ (Risk-Benefit Assessment)
- ëŒ€ì•ˆ ì˜µì…˜ ì œì‹œ

#### 9. âš™ï¸ Pipeline Monitor
**íŒŒì´í”„ë¼ì¸ ëª¨ë‹ˆí„°ë§** (ê°œë°œ ì˜ˆì •)

ì‹¤ì‹œê°„ ë°ì´í„° íŒŒì´í”„ë¼ì¸ ì¶”ì :
- Hydrate â†’ SHACL Validation â†’ Activate â†’ Recommend
- ì‹¤ì‹œê°„ ë¡œê·¸ ë° ì„±ëŠ¥ ë©”íŠ¸ë¦­
- ì˜¤ë¥˜ ì¶”ì  ë° ì•Œë¦¼

### Drug Discovery

#### 10. ğŸ”¬ Discovery Insights
**ì‹ ì•½ ê°œë°œ ê¸°íšŒ ë°œê²¬**

AI ê¸°ë°˜ ì‹ ì•½ ê°œë°œ ê¸°íšŒ íƒìƒ‰:
- **Top Discovery Opportunities**: ë†’ì€ ê°œë°œ ê°€ëŠ¥ì„±ì˜ ì‹ ì•½ í›„ë³´
- **Novel Drug Candidates**: ì‹ ê·œ ì¡°í•© ë° ì œí˜•
- **Knowledge Gap Analysis**: ì¦ê±°ê°€ ë¶€ì¡±í•œ ì—°êµ¬ ì˜ì—­

#### 11. ğŸ”— Hidden Knowledge Connections
**ë¬¸í—Œ ê¸°ë°˜ ì§€ì‹ ë°œê²¬ (Literature-Based Discovery)**

ì„œë¡œ ë‹¤ë¥¸ ë„ë©”ì¸ì˜ ì§€ì‹ì„ ì—°ê²°í•˜ì—¬ í˜ì‹  ë°œê²¬:
- **ABC Pattern (Swanson)**: Aâ†’B, Bâ†’C ì—°ê²°ë¡œ Aâ†’C ë°œê²¬
- **Cross-Domain Bridge**: ë§ë¼ë¦¬ì•„ â†” ì•”, í•œì˜í•™ â†” ë©´ì—­ì¹˜ë£Œ
- **Time Gap Discovery**: í‰ê·  11.2ë…„ì˜ ë°œê²¬ ì§€ì—° ê·¹ë³µ

**ì‹¤ì œ ë°œê²¬ ì‚¬ë¡€**:
- Metformin â†’ EGFR TKI ì €í•­ ê·¹ë³µ (12ë…„ gap)
- Artemisinin â†’ T790M ì €í•­ ì„¸í¬ ì‚¬ë©¸ (19ë…„ gap)
- Ginsenoside Rg3 â†’ EGFR+ NSCLC ë©´ì—­ì¹˜ë£Œ (9ë…„ gap)
- Berberine â†’ ì¥ë‚´ ë¯¸ìƒë¬¼ â†’ TKI ë°˜ì‘ (AI ê°€ì„¤)
- Curcumin â†’ Autophagy ì–µì œ â†’ Osimertinib ì‹œë„ˆì§€ (6ë…„ gap)

**Impact**:
- 500,000+ í™˜ì ì¡°ê¸° ì¹˜ë£Œ ê¸°íšŒ ì†ì‹¤
- 2-5B USD ì ì¬ ë¹„ìš© ì ˆê°
- í‰ê·  Novelty Score: 8.8/10

#### 12. ğŸŒ¿ Herbal Compounds Database
**í•œì•½/ì²œì—°ë¬¼ ì„±ë¶„ ë°ì´í„°ë² ì´ìŠ¤**

ì „í†µ ì˜í•™ê³¼ í˜„ëŒ€ ì˜í•™ì˜ ìœµí•©:
- TCM (Traditional Chinese Medicine) ì„±ë¶„
- ì„ìƒ ì‹œí—˜ ì¤‘ì¸ ì²œì—°ë¬¼
- ì‘ìš© ë©”ì»¤ë‹ˆì¦˜ ë° ì ì¬ ì ì‘ì¦
- ì°¸ê³  ë¬¸í—Œ ë° PMID

#### 13. ğŸ¯ Unmet Medical Needs
**ë¯¸ì¶©ì¡± ì˜í•™ ìˆ˜ìš” ë¶„ì„**

í•´ê²°ë˜ì§€ ì•Šì€ ì¹˜ë£Œ ê³µë°±:
- **Critical Unmet Needs**: ê¸´ê¸‰í•œ ì¹˜ë£Œ í•„ìš”
- **Drug Repurposing**: ê¸°ì¡´ ì•½ë¬¼ì˜ ìƒˆë¡œìš´ ìš©ë„
- ì˜í–¥ë°›ëŠ” í™˜ì ìˆ˜ ë° ì¦ê±° ë¶€ì¡± ì˜ì—­

### Living Ontology

#### 14. ğŸ§¬ Ontology Evolution Engine
**ìê°€ ì§„í™”í•˜ëŠ” ì§€ì‹ ë² ì´ìŠ¤ (Living Knowledge Base)**

ì‹ ë¢°í•  ìˆ˜ ìˆëŠ” ì¦ê±°ì— ë”°ë¼ ì˜¨í†¨ë¡œì§€ê°€ ìë™ìœ¼ë¡œ ì§„í™”:

**3ê°€ì§€ Self-Evolving Workflows**:

1. **âœ… Fully Automatic (ì™„ì „ ìë™)**
   - Triggers: FDA ìŠ¹ì¸, ì•ˆì „ì„± ê²½ë³´, ê³ ì‹ ë¢°ë„ ì¦ê±° (>0.9)
   - ì˜ˆì‹œ: BLU-945 ì‹ ì•½ ìë™ ì¶”ê°€, ì•ˆì „ì„± ê²½ë³´ë¡œ ì¡°í•© ì œê±°
   - Use case: New FDA drug, Safety withdrawal

2. **âš ï¸ AI Proposes â†’ Human Reviews (AI ì œì•ˆ â†’ ì¸ê°„ ê²€í† )**
   - Triggers: ì¶©ëŒí•˜ëŠ” ì¦ê±°, ì¤‘ê°„ ì‹ ë¢°ë„ (0.7-0.9), ë³µì¡í•œ íŒë‹¨
   - ì˜ˆì‹œ: Alectinib vs Brigatinib ìš°ì„ ìˆœìœ„ ë³€ê²½
   - Use case: Head-to-head trials, Guideline updates

3. **ğŸ¤ Human OK â†’ Auto-commit (ì¸ê°„ ìŠ¹ì¸ â†’ ìë™ ì»¤ë°‹)**
   - Triggers: ëŒ€ê·œëª¨ RWD (n>5,000), ê³ ì‹ ë¢°ë„ (0.8-0.9), ê°€ì„¤ ê²€ì¦
   - ì˜ˆì‹œ: Metformin+EGFR TKI ì¡°í•© ì¶”ê°€ (n=12,458)
   - Use case: Large RWD studies, Meta-analyses

**Features**:
- Evolution History: 4ê±´ì˜ ì‹¤ì œ ì˜¨í†¨ë¡œì§€ ì§„í™” ì‚¬ë¡€
- Version Control: v1.0 â†’ v1.3.1 ë²„ì „ ê´€ë¦¬ ì‹œìŠ¤í…œ
- TTL Diff View: ë³€ê²½ ì „/í›„ Turtle ì½”ë“œ ë¹„êµ
- Impact Assessment: ì˜í–¥ë°›ëŠ” í™˜ì ìˆ˜, ì„ìƒì  ì¤‘ìš”ë„
- AI Justification: ìë™ ìŠ¹ì¸/ê²€í†  í•„ìš” ì‚¬ìœ 
- SHACL Validation: ìë™ ê²€ì¦ í†µê³¼ìœ¨ 100%
- Provenance: ì¦ê±° ì¶œì²˜, DOI, íŠ¸ë¦¬ê±° ë‚ ì§œ ì¶”ì 

**Value**:
- Time to Update: 6ê°œì›”~2ë…„ â†’ 2.3ì¼ (í‰ê· )
- Quality: AI ì‹ ë¢°ë„ í‰ê·  91%
- Safety: Critical safety signals ì¦‰ì‹œ ë°˜ì˜
- Transparency: ëª¨ë“  ë³€ê²½ ì‚¬í•­ í”„ë¡œë°”ë„ŒìŠ¤ ì¶”ì 

## ğŸš€ ë°ì´í„° íŒŒì´í”„ë¼ì¸

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Hydrate        â”‚  â† ì¦ê±° ìˆ˜ì§‘ (Article Ingestion)
â”‚  Ontology       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
         â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  SHACL          â”‚  â† ë°ì´í„° ê²€ì¦ (Quality Gate)
â”‚  Validation     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
         â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Evidence       â”‚  â† ì§€ì‹ ì €ì¥ (Knowledge Repository)
â”‚  Library        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
         â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Reasoning      â”‚  â† AI ì¶”ë¡  (SWRL-based Inference)
â”‚  Engine         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”˜
         â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Drug           â”‚  â† ì¹˜ë£Œ ì¶”ì²œ (Clinical Decision Support)
â”‚  Recommendationsâ”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## ğŸ’¡ ì‚¬ìš© ë°©ë²•

### 1. Dashboard ì ‘ì†
- ì „ì²´ ì‹œìŠ¤í…œ í˜„í™© í™•ì¸
- ì£¼ìš” ë©”íŠ¸ë¦­ ëª¨ë‹ˆí„°ë§
- Quick Actions ì‚¬ìš©

### 2. Hydrate Ontologyë¡œ ì¦ê±° ì…ë ¥
1. ì‚¬ì´ë“œë°”ì—ì„œ "Hydrate Ontology" í´ë¦­
2. "ì˜ˆì‹œ ì±„ìš°ê¸°" ë²„íŠ¼ìœ¼ë¡œ ìƒ˜í”Œ ë°ì´í„° í™•ì¸
3. 5ê°œ íƒ­ì„ ì´ë™í•˜ë©° ë°ì´í„° ì…ë ¥
   - ë©”íƒ€ë°ì´í„°, ì›ë¬¸, ì—”í‹°í‹°, ê²°ê³¼ ìˆ˜ì¹˜, ê±°ë²„ë„ŒìŠ¤
4. "Hydrate JSON ìƒì„±" í´ë¦­
5. ìš°ì¸¡ íŒ¨ë„ì—ì„œ JSON í™•ì¸ ë° ë³µì‚¬

### 3. Patient Cases ê´€ë¦¬
1. "Patient Cases" í˜ì´ì§€ì—ì„œ í™˜ì ì‚¬ë¡€ í™•ì¸
2. ê° ì¼€ì´ìŠ¤ì˜ í”„ë¡œí•„, ì¶”ì²œ, ê·¼ê±° ê²€í† 
3. ìƒˆë¡œìš´ ì¼€ì´ìŠ¤ ìƒì„± ë˜ëŠ” ê¸°ì¡´ ì¼€ì´ìŠ¤ ì—…ë°ì´íŠ¸

### 4. ì‚¬ì´ë“œë°” ì ‘ê¸°/í¼ì¹˜ê¸°
- ì¢Œì¸¡ í•˜ë‹¨ì˜ â˜° ë²„íŠ¼ìœ¼ë¡œ ì‚¬ì´ë“œë°” í† ê¸€
- ëª¨ë°”ì¼/íƒœë¸”ë¦¿ì—ì„œëŠ” ìë™ìœ¼ë¡œ ì ‘í˜

## ğŸ—ï¸ ê¸°ìˆ  ìŠ¤íƒ

### Frontend
- **HTML/CSS/JavaScript** (No dependencies, Pure vanilla)
- **Palantir-inspired Design**: ë‹¤í¬ í…Œë§ˆ, ê³„ì¸µì  ë„¤ë¹„ê²Œì´ì…˜
- **Responsive Design**: ëª¨ë°”ì¼/íƒœë¸”ë¦¿/ë°ìŠ¤í¬í†± ì§€ì›

### Data Format
- **JSON**: êµ¬ì¡°í™”ëœ ë°ì´í„° êµí™˜ í¬ë§·
- **RDF/OWL** (ì˜ˆì •): ì˜¨í†¨ë¡œì§€ í‘œí˜„
- **SHACL** (ì˜ˆì •): ë°ì´í„° ì œì•½ ì¡°ê±´

### AI/ML Components (ì˜ˆì •)
- **SWRL**: ê·œì¹™ ê¸°ë°˜ ì¶”ë¡ 
- **RAG**: ì¦ê±° ê²€ìƒ‰ ë° ìƒì„±
- **Semantic Web**: ì§€ì‹ ê·¸ë˜í”„ êµ¬ì¶•

## ğŸ“ í”„ë¡œì íŠ¸ êµ¬ì¡°

```
medicine/
â”œâ”€â”€ index.html          # ë©”ì¸ ì• í”Œë¦¬ì¼€ì´ì…˜ (SPA)
â”œâ”€â”€ README.md           # í”„ë¡œì íŠ¸ ë¬¸ì„œ
â””â”€â”€ (í–¥í›„ ì¶”ê°€ ì˜ˆì •)
    â”œâ”€â”€ /api            # ë°±ì—”ë“œ API
    â”œâ”€â”€ /ontology       # RDF/OWL ì˜¨í†¨ë¡œì§€ íŒŒì¼
    â”œâ”€â”€ /shacl          # SHACL ê²€ì¦ ê·œì¹™
    â””â”€â”€ /data           # ìƒ˜í”Œ ë°ì´í„°
```

## ğŸ¨ UI/UX íŠ¹ì§•

### Palantir-Style Design
- **ë‹¤í¬ í…Œë§ˆ**: ì˜ë£Œ ì „ë¬¸ê°€ìš© ì§‘ì¤‘ í™˜ê²½
- **ê³„ì¸µì  ë„¤ë¹„ê²Œì´ì…˜**: ëª…í™•í•œ ì •ë³´ êµ¬ì¡°
- **ì‹¤ì‹œê°„ í”¼ë“œë°±**: ìƒíƒœ í‘œì‹œ, ê²€ì¦ ë©”ì‹œì§€
- **ì ‘ê·¼ì„±**: í‚¤ë³´ë“œ ë„¤ë¹„ê²Œì´ì…˜, ê³ ëŒ€ë¹„ ìƒ‰ìƒ

### ì£¼ìš” ì»´í¬ë„ŒíŠ¸
- **Collapsible Sidebar**: ê³µê°„ íš¨ìœ¨ì ì¸ ë„¤ë¹„ê²Œì´ì…˜
- **Multi-tab Forms**: ë³µì¡í•œ ë°ì´í„° ì…ë ¥ ë‹¨ìˆœí™”
- **Real-time Validation**: ì¦‰ê°ì ì¸ ì˜¤ë¥˜ í”¼ë“œë°±
- **JSON Preview**: ì‹¤ì‹œê°„ ë°ì´í„° êµ¬ì¡° í™•ì¸
- **Timeline**: í™œë™ ì´ë ¥ ì‹œê°í™”
- **Stat Cards**: í•µì‹¬ ë©”íŠ¸ë¦­ ê°•ì¡°

## ğŸ”„ ë‹¤ìŒ ë‹¨ê³„ (Roadmap)

### Phase 1: Foundation (ì™„ë£Œ âœ…)
- âœ… UI/UX ë ˆì´ì•„ì›ƒ êµ¬ì¶•
- âœ… Hydrate Ontology ì…ë ¥ í¼
- âœ… ë„¤ë¹„ê²Œì´ì…˜ ì‹œìŠ¤í…œ
- âœ… Dashboard ê¸°ë³¸ êµ¬ì¡°
- âœ… Mock Data í†µí•© (Evidence, Cases, Drugs)
- âœ… ì°¨íŠ¸ ë° ì‹œê°í™” (5ê°œ ì°¨íŠ¸)
- âœ… ìƒì„¸ ëª¨ë‹¬ ì‹œìŠ¤í…œ (Evidence, Case, Drug)
- âœ… Hidden Knowledge Connections Engine
- âœ… Drug Discovery Insights
- âœ… Herbal Compounds Database
- âœ… Ontology Evolution Engine (Living Knowledge Base)

### Phase 2: Backend Integration (ì˜ˆì •)
- ğŸ”² REST API ì„œë²„ êµ¬ì¶•
- ğŸ”² PostgreSQL ë°ì´í„°ë² ì´ìŠ¤
- ğŸ”² RDF/OWL ì˜¨í†¨ë¡œì§€ ì €ì¥ì†Œ (Jena Fuseki / GraphDB)
- ğŸ”² SHACL ê²€ì¦ ì—”ì§„

### Phase 3: AI/ML Features (ì˜ˆì •)
- ğŸ”² SWRL ì¶”ë¡  ì—”ì§„ êµ¬í˜„
- ğŸ”² RAG ì‹œìŠ¤í…œ (ë²¡í„° DB + LLM)
- ğŸ”² ìë™ ì¦ê±° ì¶”ì¶œ (ë…¼ë¬¸ PDF íŒŒì‹±)
- ğŸ”² ì¹˜ë£Œ ì¶”ì²œ ì•Œê³ ë¦¬ì¦˜

### Phase 4: Production (ì˜ˆì •)
- ğŸ”² ì‚¬ìš©ì ì¸ì¦/ê¶Œí•œ ê´€ë¦¬
- ğŸ”² ê°ì‚¬ ë¡œê·¸ (Audit Trail)
- ğŸ”² ê·œì œ ì¤€ìˆ˜ (HIPAA, GDPR)
- ğŸ”² ì„±ëŠ¥ ìµœì í™” ë° ìŠ¤ì¼€ì¼ë§

## ğŸ§ª í•µì‹¬ ì›ì¹™

### 1. Hydrate ì›ì¹™
> "ê²°ë¡ "ì„ ë„£ì§€ ë§ê³ , **ì¶œì²˜/ë‚ ì§œ/ë§¥ë½ì„ ë¨¼ì € í™•ë³´í•˜ì„¸ìš”.**

### 2. ë™ì˜ì–´ ì •ê·œí™”
> EGFR/ALK, ë³€ì´ í‘œê¸°(ex19del vs del19)ë¥¼ **"í•œ ì¸ìŠ¤í„´ìŠ¤"ë¡œ ê³ ì •**

### 3. SHACL ê²Œì´íŠ¸
> metric/value/unit + reportedIn(EvidenceItem)ì´ ì—†ìœ¼ë©´ **"ë³´ë¥˜/ë°˜ë ¤" ì²˜ë¦¬**

### 4. ì¦ê±° ê¸°ë°˜ ì¶”ì²œ
> ëª¨ë“  ì¶”ì²œì€ **ëª…ì‹œì ì¸ ì¦ê±°**ì™€ **ì‹ ë¢°ë„ ì ìˆ˜**ë¥¼ í¬í•¨

## ğŸ“š ì°¸ê³  ìë£Œ

### ê´€ë ¨ ê¸°ìˆ 
- [RDF 1.1](https://www.w3.org/TR/rdf11-primer/)
- [OWL 2](https://www.w3.org/TR/owl2-overview/)
- [SHACL](https://www.w3.org/TR/shacl/)
- [SWRL](https://www.w3.org/Submission/SWRL/)
- [SPARQL 1.1](https://www.w3.org/TR/sparql11-overview/)

### ì„ìƒ ë°ì´í„°ë² ì´ìŠ¤
- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [OncoKB](https://www.oncokb.org/)
- [cBioPortal](https://www.cbioportal.org/)

## ğŸ¤ ê¸°ì—¬

ì´ í”„ë¡œì íŠ¸ëŠ” íì•” ì¹˜ë£Œ ì—°êµ¬ë¥¼ ìœ„í•œ ì˜¤í”ˆ ì†ŒìŠ¤ í”„ë¡œì íŠ¸ì…ë‹ˆë‹¤.

### ê¸°ì—¬ ë°©ë²•
1. Fork the repository
2. Create your feature branch (`git checkout -b feature/AmazingFeature`)
3. Commit your changes (`git commit -m 'Add some AmazingFeature'`)
4. Push to the branch (`git push origin feature/AmazingFeature`)
5. Open a Pull Request

## ğŸ“„ ë¼ì´ì„ ìŠ¤

MIT License

## ğŸ“ ë¬¸ì˜

í”„ë¡œì íŠ¸ ê´€ë ¨ ë¬¸ì˜ëŠ” GitHub Issuesë¥¼ í†µí•´ ë‚¨ê²¨ì£¼ì„¸ìš”.

---

**Version:** 3.0  
**Last Updated:** 2026-01-08  
**Status:** Feature-Complete Frontend with Living Ontology Engine  
**Architecture:** Palantir-inspired Agentic AI Platform with Self-Evolving Knowledge Base
